Novus Biologicals IRF7 Peptide
Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
Manufacturer: Novus Biologicals NBP177264PEP
DescriptionA blocking peptide containing 14 amino acids near the center terminus of human IRF7. Source: Synthetic (Accession #: Q92985) The IRF7 Blocking Peptide has been validated for the following applications: Antibody Competition.
|For blocking activity of IRF7, NBP1-77264|
|PBS pH 7.2 (10mM NAH2PO4, 10mM Na2HPO4, 130mM NaCl) containing 0.1% bovine serum albumin.|
|14 amino acids near the center terminus of human IRF7|
|−20°C. Avoid freeze-thaw cycles.|